181 related articles for article (PubMed ID: 38127276)
1. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia.
Kubota H; Ueno H; Tasaka K; Isobe T; Saida S; Kato I; Umeda K; Hiwatari M; Hasegawa D; Imamura T; Kakiuchi N; Nannya Y; Ogawa S; Hiramatsu H; Takita J
Blood Adv; 2024 Mar; 8(5):1258-1271. PubMed ID: 38127276
[TBL] [Abstract][Full Text] [Related]
2. High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes.
Fernández-Sevilla LM; Valencia J; Ortiz-Sánchez P; Fraile-Ramos A; Zuluaga P; Jiménez E; Sacedón R; Martínez-Sánchez MV; Jazbec J; Debeljak M; Fedders B; Stanulla M; Schewe D; Cario G; Minguela A; Ramírez M; Varas A; Vicente Á
Blood; 2022 Jun; 139(22):3303-3313. PubMed ID: 35313334
[TBL] [Abstract][Full Text] [Related]
3. PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.
Bedics G; Egyed B; Kotmayer L; Benard-Slagter A; de Groot K; Bekő A; Hegyi LL; Bátai B; Krizsán S; Kriván G; Erdélyi DJ; Müller J; Haltrich I; Kajtár B; Pajor L; Vojcek Á; Ottóffy G; Ujfalusi A; Szegedi I; Tiszlavicz LG; Bartyik K; Csanádi K; Péter G; Simon R; Hauser P; Kelemen Á; Sebestyén E; Jakab Z; Matolcsy A; Kiss C; Kovács G; Savola S; Bödör C; Alpár D
Br J Cancer; 2023 Aug; 129(3):455-465. PubMed ID: 37340093
[TBL] [Abstract][Full Text] [Related]
4. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia.
Llaurador G; Shaver K; Wu M; Wang T; Gillispie A; Doherty E; Craddock J; Read J; Yassine K; Morales E; George A; Steffin D; Krance R; Martinez C; Heslop H; Salem B
Transplant Cell Ther; 2024 Feb; 30(2):217-227. PubMed ID: 37931800
[TBL] [Abstract][Full Text] [Related]
5. miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
Avigad S; Verly IR; Lebel A; Kordi O; Shichrur K; Ohali A; Hameiri-Grossman M; Kaspers GJ; Cloos J; Fronkova E; Trka J; Luria D; Kodman Y; Mirsky H; Gaash D; Jeison M; Avrahami G; Elitzur S; Gilad G; Stark B; Yaniv I
Genes Chromosomes Cancer; 2016 Apr; 55(4):328-39. PubMed ID: 26684414
[TBL] [Abstract][Full Text] [Related]
6. Genes Involved in miRNA Biogenesis Are Not Downregulated in SARS-CoV-2 Infection.
Garnier N; Sane F; Massara L; Soncin F; Gosset P; Hober D; Szunerits S; Engelmann I
Viruses; 2023 May; 15(5):. PubMed ID: 37243263
[TBL] [Abstract][Full Text] [Related]
7. Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia.
Amankwah EK; Devidas M; Teachey DT; Rabin KR; Brown PA
Anticancer Res; 2020 Jun; 40(6):3147-3153. PubMed ID: 32487609
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia.
Lim EL; Trinh DL; Ries RE; Wang J; Gerbing RB; Ma Y; Topham J; Hughes M; Pleasance E; Mungall AJ; Moore R; Zhao Y; Aplenc R; Sung L; Kolb EA; Gamis A; Smith M; Gerhard DS; Alonzo TA; Meshinchi S; Marra MA
J Clin Oncol; 2017 Dec; 35(35):3964-3977. PubMed ID: 29068783
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
[TBL] [Abstract][Full Text] [Related]
10. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
11. The Importance of Selected Dysregulated microRNAs in Diagnosis and Prognosis of Childhood B-Cell Precursor Acute Lymphoblastic Leukemia.
Ziętara KJ; Lejman J; Wojciechowska K; Lejman M
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672378
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases.
Bhatia P; Singh M; Singh A; Sharma P; Trehan A; Varma N
Int J Lab Hematol; 2021 Oct; 43(5):1016-1023. PubMed ID: 33538126
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma.
Xie M; Lv Y; Liu Z; Zhang J; Liang C; Liao X; Liang R; Lin Y; Li Y
Cancer Manag Res; 2018; 10():5759-5766. PubMed ID: 30532596
[TBL] [Abstract][Full Text] [Related]
14. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
Enshaei A; Vora A; Harrison CJ; Moppett J; Moorman AV
Lancet Haematol; 2021 Nov; 8(11):e828-e839. PubMed ID: 34715050
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of miRNA-mRNA interaction in pediatric dilated cardiomyopathy.
Hailu FT; Karimpour-Fard A; Toni LS; Bristow MR; Miyamoto SD; Stauffer BL; Sucharov CC
Pediatr Res; 2022 Jul; 92(1):98-108. PubMed ID: 34012027
[TBL] [Abstract][Full Text] [Related]
16. An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse.
Bartsch L; Schroeder MP; Hänzelmann S; Bastian L; Lázaro-Navarro J; Schlee C; Tanchez JO; Schulze V; Isaakidis K; Rieger MA; Gökbuget N; Eckert C; Serve H; Horstmann M; Schrappe M; Brüggemann M; Baldus CD; Neumann M
BMC Genom Data; 2022 Apr; 23(1):30. PubMed ID: 35436854
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
[TBL] [Abstract][Full Text] [Related]
18. Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients.
Yang L; Dao FT; Lu AD; Chen WM; Li LD; Long LY; Liu YR; Liu KY; Zhang LP; Qin YZ
Pediatr Hematol Oncol; 2022 Mar; 39(2):97-107. PubMed ID: 34156313
[TBL] [Abstract][Full Text] [Related]
19. Low expression of
Cui L; Gao C; Wang CJ; Liu SG; Wu MY; Zhang RD; Li ZG
Pediatr Hematol Oncol; 2020 Nov; 37(8):732-746. PubMed ID: 32804017
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.
Longjohn MN; Squires WRB; Christian SL
Gene; 2022 May; 821():146211. PubMed ID: 35134470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
